About Annelise Barron
Form D filings for Maxwell Biosciences from 2022 to 2023 list Annelise Barron as director.
Annelise Barron first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Annelise Barron in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Annelise Barron works with at each company, as listed on that company's latest Form D.
Maxwell Biosciences, Inc. · Form D, Jul 14, 2023
JM
Joshua McClure
President and CEO, director
KM
Kate McKinley
Director
PT
Praveen Tyle
Director
BH
Barbara Holcomb
Director